Oct 20, 2026 08:30AM
Oct 20, 2026 08:30AM
Oct 8, 2026 08:00AM
Aug 5, 2026 08:00AM
Jul 7, 2026 06:00AM
Jun 9, 2026 06:00AM
Jun 1, 2026 10:00PM Lobe Sciences Announces Proposed Shares for Debt Transaction
May 6, 2026 08:00PM
May 6, 2026 06:00AM
Feb 3, 2026 07:00AM
Jan 8, 2026 08:55AM
Jan 6, 2026 06:00AM
Sep 9, 2025 11:50PM
Jun 17, 2025 11:58PM Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals
Apr 4, 2025 11:50PM
Oct 16, 2024 07:36PM
Oct 2, 2024 07:30AM
May 31, 2024 07:30AM
Jun 27, 2023 07:45AM
Mar 22, 2023 09:01AM
Jan 26, 2023 08:30AM Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache
Jan 18, 2023 07:00AM
Sep 1, 2022 09:22AM
Aug 10, 2022 09:16AM

335,387 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All